FIELD: medicine, pharmaceutics.
SUBSTANCE: present invention refers to new 2-thyoxanthene derivatives, namely to a compound of formula 
or its pharmaceutically acceptable salt, representing: 3-(2-ethoxy-2-methylpropyl)-2-thyoxantene; 3 (2-propoxy-2-methylpropyl)-2-thyoxanteme; 3-(2-methoxy-2-methylpropyl)-2-thyoxantene; 3 (2-isopropoxyethyl)-2-thyoxantene; 3 (2-ethoxypropyl)-2-thyoxantene; 3 (2S-ethoxypropyl)-2-thyoxantene; 3-(2R-ethoxypropyl)-2-thyoxantene. Also, the invention refers to a pharmaceutical composition on the basis of the compound of formula I, to application of the compound of formula I in preparing a drug.
EFFECT: new 2-thyoxantene derivatives effective for MPO (myeloperoxidase) enzyme inhibition.
9 cl, 1 tbl, 6 ex
| Title | Year | Author | Number |
|---|---|---|---|
| NEW PYRROLO[3,2-d]PYRIMIDIN-4-ONE DERIVATIVES AND USING THEM IN THERAPY | 2005 |
|
RU2577858C2 |
| 4-AMINO-IMIDAZOQUINOLINE DERIVATIVES, USEFUL IN TREATING DISEASES MEDIATED BY TLR7 AND/OR TLR8 AGONISTS | 2015 |
|
RU2698902C2 |
| 1-(2-ISOPROPOXYETHYL)-2-THIOXO-1,2,3,5-TETRAHYDRO-PYRROLO[3,2-d]PYRIMIDIN-4-ONE AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF | 2005 |
|
RU2409578C2 |
| 3-PHENOXYMETHYL-PYRROLIDINE COMPOUNDS | 2010 |
|
RU2535669C2 |
| COMBINATION OF COMPOUNDS, WHICH CAN BE APPLIED IN TREATMENT OF RESPIRATORY DISEASES, ESPECIALLY CHRONICAL OBSTRUCTIVE LUNG DISEASE (COLD) AND ASTHMA | 2006 |
|
RU2414222C2 |
| IMIDAZOLE DERIVATIVES ACTIVE TO CB1 RECEPTOR | 2005 |
|
RU2377238C2 |
| TRIAZOLES FOR REGULATION OF INTRACELLULAR CALCIUM HOMEOSTASIS | 2017 |
|
RU2753509C2 |
| OXADIAZOLE DERIVATIVES AND USE THEREOF AS METABOTROPIC GLUTAMATE RECEPTOR POTENTIATORS 842 | 2008 |
|
RU2470931C2 |
| NOVEL 5,7-DISUBSTITUTED [1,3]THIAZOLO[4,5-d]PYRIMIDINE-2-(3H)-AMINE DERIVATIVES AND USE THEREOF IN THERAPY | 2007 |
|
RU2437889C2 |
| DERIVATIVES OF 1,3,4-OXADIAZOLONE, PHARMACEUTICAL COMPOSITION BASED ON THEREOF AND METHOD OF TREATMENT | 1999 |
|
RU2202548C2 |
